171
Views
1
CrossRef citations to date
0
Altmetric
Systematic Review

Sickle cell disease in gulf cooperation council countries: a systematic review

, , , , , , , & show all
Pages 893-909 | Received 04 May 2021, Accepted 30 Sep 2022, Published online: 18 Oct 2022

References

  • Farrell K, Dent L, Nguyen ML, et al. The relationship of oxygen transport and cardiac index for the prevention of sickle cell crises. J Natl Med Assoc. 2010;102(11):1000–1008.
  • Asnani MR, Quimby KR, Bennett NR, et al. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications. Cochrane Database Syst Rev. 2016;6(10):CD011175.
  • Bello-Manga H, DeBaun MR, Kassim AA. Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa. Expert Rev Hematol. 2016;9(11):1031–1042.
  • Piel FB. The present and future global burden of the inherited disorders of hemoglobin. Hematol Oncol Clin North Am. 2016;30(2):327–341.
  • Makani J, Cox SE, Soka D, et al. Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PloS one. 2011;6(2):2.
  • Makani J, Williams T, Marsh K. Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol. 2007;101(1):3–14.
  • AlHamdan NA, AlMazrou YY, AlSwaidi FM, et al. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med. 2007;9(6):372–377.
  • Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011;31(3):289–293.
  • Aygun B, Odame I. A global perspective on sickle cell disease. Pediatr Blood Cancer. 2012;59(2):386–390.
  • Quinn CT, Rogers ZR, McCavit TL, et al. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115(17):3447–3452.
  • Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.
  • Mulumba LL, Wilson L. Sickle cell disease among children in Africa: an integrative literature review and global recommendations. Int J Afr Nurs Sci. 2015;3:56–64.
  • Haywood JC, Beach MC, Lanzkron S, et al. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc. 2009;101(10):1022–1033.
  • Al Salman J, Al Agha RA, Al Taitoon S, et al. Fever in sickle cell disease patients in the Kingdom of Bahrain. J Infect Public Health. 2014;7(4):333–338.
  • Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–1048.
  • Soe HH, Abas AB, Than NN, et al. Vitamin D supplementation for sickle cell disease. Cochrane Database Syst Rev. 2017;(1):CD010858
  • Ebert EC, Nagar M, Hagspiel KD. Gastrointestinal and hepatic complications of sickle cell disease. Clin Gastroenterol Hepatol. 2010;8(6):483–489.
  • El Hoss S, Brousse V. Considering the spleen in sickle cell disease. Expert Rev Hematol. 2019;12(7):563–573.
  • Memish ZA, Saeedi MY. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia. Ann Saudi Med. 2011;31(3):229–235.
  • Hamamy HA, Al-Allawi NA. Epidemiological profile of common hemoglobinopathies in Arab countries. J Community Genet. 2013;4(2):147–167.
  • Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349(jan02 1):g7647.
  • Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed. 2020;19(March):2020.
  • Herzog R, Álvarez-Pasquin MJ, Díaz C, et al. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health. 2013;13(1):154.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
  • Amr M, Amin T, Hablas H. Psychiatric disorders in a sample of Saudi Arabian adolescents with sickle cell disease. Child Youth Care Forum. 2009;39(3):151–166.
  • Al Jabr I. Hearing loss among adults with sickle cell disease in an endemic region: a prospective case-control study. Ann Saudi Med. 2016;36(2):135–138.
  • Mohammed S, Addae S, Suleiman S, et al. Serum calcium, parathyroid hormone, and vitamin D status in children and young adults with sickle cell disease. Ann Clin Biochem. 1993;30(1):45–51.
  • Wagdy R, Suliman H, Bamashmose B, et al. Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease. Eur J Pediatr. 2018;177(12):1745–1752.
  • El-Hazmi M, Bahakim H, Al-Fawaz I. Endocrine functions in sickle cell anaemia patients. J Trop Pediatr. 1992;38(6):307–313.
  • El-Hazmi M, Comparative A. Study of haematological parameters in children suffering from Sickle Cell Anaemia (SCA) from different regions of Saudi Arabia. J Trop Pediatr. 2001;47(3):136–141.
  • El-Hazmi MA, Warsy AS. On the nature of sickle cell disease in the south-western province of Saudi Arabia. Acta Haematol. 1986;76(4):212–216.
  • el-Hazmi MA. Clinical manifestation and laboratory findings of sickle cell anaemia in association with alpha-thalassaemia in Saudi Arabia. Acta Haematol. 1985;74(3):155–160.
  • Natural PR. History of Sickle Cell Anemia in Saudi Arabs. Ann Intern Med. 1978;88(1):1.
  • Al Jama FE, Gasem T, Burshaid S, et al. Pregnancy outcome in patients with homozygous sickle cell disease in a University hospital, Eastern Saudi Arabia. Arch Gynecol Obstet. 2009;280(5):793–797.
  • Al Kahtani MA, AlQahtani M, Alshebaily MM, et al. Morbidity and pregnancy outcomes associated with sickle cell anemia among Saudi women. Int J Gynaecol Obstet. 2012;119(3):224–226.
  • MI EM, BH AA, Absood G. Infections and sickle cell disease in Eastern Saudi Arabian children. Am J Dis Child. 1989;143(2):205–207.
  • Babiker M, Taha S. Two different patterns of sickle cell disease in children in Saudi Arabia. Ann Trop Paediatr. 1982;2(4):179–181.
  • Perrine R, John P, Pembrey M, et al. Sickle cell disease in Saudi Arabs in early childhood. Arch Dis Child. 1981;56(3):187–192.
  • Acquaye J, Omer A, Ganeshaguru K, et al. Non-benign sickle cell anaemia in western Saudi Arabia. Br J Haematol. 1984;60(1):99–108.
  • Memish Z, Owaidah T, Saeedi M. Marked regional variations in the prevalence of sickle cell disease and β-thalassemia in Saudi Arabia: findings from the premarital screening and genetic counseling program. J Epidemiol Glob Health. 2011;1(1):61.
  • El Mouzan MI, Al Awamy BH, Al Torki MT, et al. Variability of sickle cell disease in the Eastern Province of Saudi Arabia. J Pediatr. 1989;114(6):973–976.
  • Al-Suleiman A, Aziz G, Bagshia M, et al. Acute chest syndrome in adult sickle cell disease in eastern Saudi Arabia. Ann Saudi Med. 2005;25(1):53–55.
  • Al-Dabbous IA. Acute chest syndrome in sickle cell disease in Saudi Arab children in the Eastern Province. Ann Saudi Med. 2002;22(3–4):167–171.
  • Srair HA, Owa JA, Aman HA, et al. Acute chest syndrome in children with sickle cell disease. Indian J Pediatr. 1995;62(2):201–205.
  • Al-Khoufi EA. Prevalence of pulmonary arterial hypertension among sickle cell disease patients in Al Hassa. Glob J Health Sci. 2013;5(5):174–180.
  • Alsubaie S, Almathami M, Abouelyazid A, et al. Prevalence of depression among adults with sickle cell disease in the Southern Region of Saudi Arabia. Pak J Med Sci. 2018;34(4):4.
  • Al-Hazzaa S, Bird A, Kulozik A, et al. Ocular findings in Saudi Arabian patients with sickle cell disease. Br J Ophthalmol. 1995;79(5):457–461.
  • Al-Ali A, Ahmed M, Qaw F, et al. Uric acid, creatinine and urea in normal, glucose-6-phosphate dehydrogenase-Deficient and Hb SS Saudi Subjects. Acta Haematol. 1995;94(2):114–116.
  • AlJama A, AlKhalifah M, Al-Dabbous I, et al. Vitamin D deficiency in sickle cell disease patients in the Eastern Province of Saudi Arabia. Ann Saudi Med. 2018;38(2):130–136.
  • Ahmed A, Ali Y, Alsuliman A, et al. The prevalence of abnormal leukocyte count, and its predisposing factors, in patients with sickle cell disease in Saudi Arabia. J Blood Med. 2017;8:185–191.
  • Zia S, Rafique M. Comparison of pregnancy outcomes in women with sickle cell disease and trait. J Pak Med Assoc. 2013;63(6):743–746.
  • Turki H. Influence of pregnancy on bone mass in sickle cell anemia. West Afr J Med. 2009;28(3):3.
  • HASSAN H, Mughal I, DAR J, et al. Significant bronchospasm during sickle cell painful crises is associated with a lower peripheral eosinophil count. Respirology. 2006;11(5):633–637.
  • Al-Otaibi T, Al-Qwaiee M, Faraidi H, et al. Prevalence of obstructive sleep apnea in children with sickle cell disease at a tertiary hospital in Saudi Arabia. Saudi Med J. 2017;38(6):616–620.
  • Al-Trabolsi H, Alshehri M. Acute chest syndrome in children with sickle cell disease. Bahrain Med Bull. 2005;27:119–122.
  • Alameri HF, Aleem A, Kardas W, et al. Dyspnea, pulmonary function and exercise capacity in adult Saudi patients with sickle cell disease. Saudi Med J. 2008 May 1;29(5):707.
  • Alkhunaizi A, Al-Khatti A, Alkhunaizi M. Prevalence of microalbuminuria in adult patients with sickle cell disease in Eastern Saudi Arabia.Int J Nephrol. 2018;2018:1–6.
  • Sadat-Ali M, Ammar A, Corea JR, et al. The spine in sickle cell disease. Int Orthop. 1994 Jun;18(3):154–156.
  • Mallouh A, Bone TY. Joint infection in patients with sickle cell disease. J Pediatr Orthop. 1985;5(2):158–162.
  • Al-Salem A, Ahmed H, Qaisaruddin S, et al. Osteomyelitis and septic arthritis in sickle cell disease in the eastern province of Saudi Arabia. Int Orthop. 1992;16(4):4.
  • Sadat-Ali M, Geeranavar S, As-Suhaimi S. Orthopedic complications in sickle cell disease-A comparative study from two regions in Saudi Arabia. Int Orthop. 1992;16(3):3.
  • Sadat-Ali M, Al-Elq AH, Sultan O, et al. Low bone mass due to sickle cell anemia: is it becoming a real issue? West Afr J Med. 2008 Oct 1;27:4.
  • Aleem A, Jehangir A, Owais M, et al. Echocardiographic abnormalities in adolescent and adult Saudi patients with sickle cell disease. Saudi Med J. 2007 Jul 1;28(7):1072.
  • Abo-Zenah H, Moharram M, El Nahas A. Cardiorenal risk prevalence in sickle cell hemoglobinopathy. Nephron Clin Pract. 2009;112(2):c98–106.
  • Al-Awamy B, Taha S, Naeem M. Priapism in association with sickle cell anemia in Saudi Arabia. Acta Haematol. 1985;73(3):181–182.
  • Al-Awamy B, Wilson WA, Pearson HA, Al-Awamy B, Wilson WA, Pearson HA. Splenic function in sickle cell disease in the Eastern Province of Saudi Arabia. J Pediatr. 1984;104(5):714–717.
  • Aleem A. Renal abnormalities in patients with sickle cell disease: a single center report from Saudi Arabia. Saudi J Kidney Dis Transpl. 2008 Mar 1;19(2):194.
  • Badr M, El Koumi M, Ali Y, et al. Renal tubular dysfunction in children with sickle cell hemoglobinopathy. Nephrology (Carlton). 2013;18(4):299–303.
  • Wali S, AlQassas I, Merdad R, et al. Restless legs syndrome and sleep quality among adult sickle cell disease patients. Sleep Breath. 2017;22(2):495–501.
  • Kotb MM, Tantawi WH, Elsayed AA, et al. Brain MRI and CT findings in sickle cell disease patients from Western Saudi Arabia. Neurosciences (Riyadh). 2006 Jan 1;11(1):28–36.
  • Nasserullah Z, Alshammari A, Al Abbas M, et al. Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency. Ann Saudi Med. 2003;23(6):354–357.
  • Al-Awamy B, Al-Muzan M, Al-Turki M, et al. Neonatal screening for sickle cell disease in the Eastern Province of Saudi Arabia.Trans. R Soc Trop Med Hyg. 1984;78(6):792–794.
  • Al-Qurashi MM, El-Mouzan MI, Al-Herbish AS, et al. The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey. Saudi Med J. 2008 Oct 1;29(10):1480–1483.
  • Alsaeed E, Farhat G, Assiri A, et al. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011–2015. J Epidemiol Glob Health. 2017;7(S1):S41.
  • Alsaeed A. Prevalence of hemoglobinopathy disorders in adult patients sent for diagnosis of Anemia in Saudi Arabia. Genet Test Mol Biomarkers. 2012;16(1):25–29.
  • Alsultan A, Aleem A, Ghabbour H, et al. Sickle cell disease subphenotypes in patients from Southwestern Province of Saudi Arabia. J Pediatr Hematol Oncol. 2012;34(2):79–84.
  • Alsultan A, Alabdulaali M, Griffin P, et al. Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign. Br J Haematol. 2013;164(4):597–604.
  • El-Hazmi MA, Jabbar FA, Al-Faleh FZ, et al. Patterns of sickle cell, thalassaemia and glucose-6-phosphate dehydrogenase deficiency genes in northwestern Saudi Arabia. Hum Hered. 1991;41(1):26–34.
  • Al-Awamy BH, Niazi GA, el-Mouzan MI, et al. Relationship of hemoglobin F and alpha thalassaemia to severity of sickle-cell anemia in the Eastern Province of Saudi Arabia. Ann Trop Paediatr. 1986;6(4):261–265.
  • Gelpi AP, King MC, Gelpi AP, King MC. Screening for abnormal hemoglobins in the Middle East: new data on hemoglobin S and the presence of hemoglobin C in Saudi Arabia. Acta Hematol. 1976;56(6):334–337.
  • el-Hazmi MA, Warsy AS, al-Swailem AR, et al. Sickle cell gene in the population of Saudi Arabia. Hemoglobin. 1996;20(3):187–198.
  • Gelpi A. Benign sickle cell disease in Saudi Arabia: survival estimate and population dynamics. Clin Genet. 2008;15(4):307–310.
  • El Mouzan MI, Al Salloum AA, Al Herbish AS, et al. Consanguinity and major genetic disorders in Saudi children: a community-based cross-sectional study. Ann Saudi Med. 2008;28(3):169–173.
  • El Mouzan MI, Al Awamy BH, Al Torki MT. Clinical features of sickle cell disease in eastern Saudi Arab children. Am J Pediatr Hematol Oncol. 1990;12(1):51–55.
  • El-Hazmi MA. Clinical and hematological diversity of sickle cell disease in Saudi children. J Trop Pediatr. 1992;38(3):106–112.
  • Izuora GI, Al-Dusari SN, Fakunle YM. Sickle cell anemia morbidity in Northern Saudi Arabia. Saudi Med J. 2003;24(3):269–272.
  • El-Hazmi M, Warsy A, Bahakim H, et al. Glucose-6-phosphate dehydrogenase deficiency and the sickle cell gene in Makkah, Saudi Arabia. J Trop Pediatr. 1994;40(1):12–16.
  • Pejaver RK, Ahmad F, Bedawi H. Sickle cell anemia in Saudi-Arabian children. J R Soc Health. 1995;115(3):156–158.
  • Sickle Cell GA. Disease in Saudi Arabs. Acta Hematol. 1970;43(2):89–99.
  • Warsy A. Frequency of glucose-6-phosphate dehydrogenase deficiency in sickle-cell disease. Hum Hered. 1985;35(3):143–147.
  • Mulik R, Butikofer A, Aramouni G, et al. A clinico-epidemiological study of sickle cell anemia in Saudi Arabia. J Trop Pediatr. 1991;37(3):100–105.
  • Samuel A, Saha N, Acquaye J, et al. Association of red cell glucose-6-phosphate dehydrogenase with hemoglohinopathies. Hum Hered. 1986;36(2):107–112.
  • Padmos MA, Sackey K, Roberts GT, et al. Two different forms of homozygous sickle cell disease occur in Saudi Arabia. Br J Haematol. 1991;79(1):93–98.
  • El-Shafei A, Kaur Dhaliwal J, Kaur Sandhu A. Pregnancy in sickle cell disease in Bahrain. Br J Obstet Gynaecol. 1992;99(2):101–104.
  • Garadah T, Hassan A, Jaradat A, et al. Predictors of abnormal bone mass density in adult patients with homozygous sickle-cell disease. Clin Med Insights Endocrinol Diabetes. 2015,8;35–40.
  • Garadah T, Jaradat A, Al Alalawi M, et al. Hormonal and echocardiographic abnormalities in adult patients with sickle-cell anemia in Bahrain. J Blood Med. 2016;7:283–289.
  • Rajab K, Issa A, Mohammed A, et al. Sickle cell disease and pregnancy in Bahrain. Int J Gynaecol Obstet. 2006;93(2):171–175.
  • Mahdi N, Al-Ola K, Khalek N, et al. Depression, anxiety, and stress comorbidities in sickle cell anemia patients with vaso-occlusive crisis. J Pediatr Hematol Oncol. 2010;32(5):345–349.
  • Ei-Shafei A, Sandhu A, Dhaliwal J. Maternal mortality in Bahrain with special reference to sickle cell disease. Aust N Z J Obstet Gynaecol. 1988;28(1):41–44.
  • Shome D, Ramadorai P, Al-Ajmi A, et al. Thrombotic microangiopathy in sickle cell disease crisis. Ann Hematol. 2013;92(4):509–515.
  • Abdulla M, Almoosa F, Al Moosa R, et al. A prospective study of the association between sickle cell disease and hepatobiliary effects in Bahrain. Int J Gen Med. 2017;10:221–226.
  • Rasromani K, Jamsheer N, Mohammed A, et al. Prevalence of cholelithiasis in sickle cell disease. Med Princ Pract. 1990;2(3–4):182–184.
  • Al-Mahroos F, Ebrahim A. Prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers among patients with hereditary hemolytic anemias. Ann Trop Pediatr. 1995;15(2):121–128.
  • Mohammed AM, Al-Hilli F, Nadkarni KV, et al. Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain. Ann Saudi Med. 1992;12(6):536–539.
  • Al-Arrayed S, Hafadh N, Amin S, et al. Student screening for inherited blood disorders in Bahrain. East Mediterr Health J. 2003;9(3):344–352.
  • Gupta R, Marouf R, Adekile A. Pattern of bone mineral density in sickle cell disease patients with the high-hb f phenotype. Acta Haematol. 2009;123(1):64–70.
  • Marouf R, Behbehani N, Zubaid M, et al. Transthoracic echocardiography and 6-minute walk test in Kuwaiti Sickle Cell Disease Patients. Med Princ Pract. 2014;23(3):212–217.
  • Akar NA, Adekile A. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait. Med Princ Pract. 2008;17(5):404–408.
  • Adekile AD, Haider MZ. Morbidity, beta S haplotype and alpha-globin gene patterns among sickle cell anemia patients in Kuwait. Acta Haematol. 1996;96(3):150–154.
  • Okbi M, Alkindi S, Al Abri R, et al. Pathare A. Sensorineural hearing loss in sickle cell disease-A prospective study from Oman. Laryngoscope. 2011;121(2):392–396.
  • Soliman A, Bassiouny M, Elbanna N. Study of hepatic functions and prevalence of hepatitis-B surface antigenaemia in Omani children with sickle cell disease. J Trop Pediatr. 1995;41(3):174–176.
  • Al-Farsi SH, Al-Khabori MK, Al-Hunieni MN, et al. Fetal outcomes in pregnant women with sickle cell disease. Saudi Med J. 2014;35(5):472–476.
  • Al-Farsi SH, Al-Riyami NM, Al-Khabori MK, et al. Maternal complications and the association with baseline variables in pregnant women with sickle cell disease. Hemoglobin. 2013;37(3):219–226.
  • Jaiyesimi O, Kasem M. Acute chest syndrome in Omani children with sickle cell disease: epidemiology and clinical profile. Ann Trop Paediatr. 2007;27(3):193–199.
  • Al-Riyami AA, Suleiman AJ, Afifi M, et al. A community-based study of common hereditary blood disorders in Oman. East Mediterr Health J. 2001;7(6):1004–1011.
  • Barakat-Haddad C. Prevalence of high blood pressure, heart disease, thalassemia, sickle-cell anemia, and iron-deficiency anemia among the UAE adolescent population. J Environ Public Health. 2013;2013:680631.
  • Al Hosani H, Salah M, Osman HM, et al. Incidence of hemoglobinopathies detected through neonatal screening in the United Arab Emirates. East Mediterr Health J. 2005;11(3):300–307.
  • Fawzi ZO, Hilali A, Fakhroo N, et al. Distribution of Hemoglobinopathies and Thalassemias in Qatari Nationals Seen at Hamad Hospital in Qatar. Qatar Med J. 2003;12:20–24.
  • Al-Salem M, Ismail L. Ocular manifestations of sickle cell anemia in Arab children. Ann Trop Pediatr. 1990;10(2):199–202.
  • Sarri G, Bhor M, Abogunrin S, et al. Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease. Health Qual Life Outcomes. 2018;16(1):99.
  • Wastnedge E, Waters D, Patel S, et al. The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis. J Glob Health. 2018;8(2):021103.
  • Uyoga S, Macharia AW, Mochamah G, et al. The epidemiology of sickle cell disease in children recruited in infancy in Kilifi, Kenya: a prospective cohort study. Lancet Glob Health. 2019;7(10):e1458–66.
  • Noubiap JJ, Mengnjo MK, Nicastro N, et al. Neurologic complications of sickle cell disease in Africa: a systematic review and meta-analysis. Neurology. 2017;89(14):1516–1524.
  • Lehmann H, Maranjian G, Mourant AE. Distribution of sickle-cell hemoglobin in Saudi Arabia. Nature. 1963;198(4879):492–493.
  • Kamel K. Sickle cell hemoglobin: origin and clinical manifestations in Arabs and relation to fetal hemoglobin levels. Qatar Med J. 1984;5(1):23–26.
  • Ali SA. Milder variant of sickle-cell disease in Arabs in Kuwait associated with unusually high level of fetal hemoglobin. Br J Hematol. 1970;19(5):613–619.
  • Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet. 2005;77(2):171–192.
  • Tewari S, Brousse V, Piel FB, et al. Environmental determinants of severity in sickle cell disease. Haematologica. 2015;100(9):1108–1116.
  • Powars DR, Chan LS, Hiti A, et al. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore). 2005;84(6):363–376.
  • Piel FB, Hay SI, Gupta S, et al. Global burden of sickle cell anemia in children under five, 2010-2050: modeling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10(7):e1001484.
  • Mburu J, Odame I. Sickle cell disease: reducing the global disease burden. Int J Lab Hematol. 2019;41(Suppl 1):82–88.
  • Zaidi AU, Glaros AK, Lee S, et al. A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease. Orphanet J Rare Dis. 2021;16(1):460.
  • Bhinder MA, Sadia H, Mahmood N, et al. Consanguinity: a blessing or menace at population level? Ann Hum Genet. 2019;83(4):214–219.
  • Naoum PC. Hemoglobinopatias e talassemias. São Paulo: Sarvier. 1997;51–71.
  • Adachi K, Kim J, Ballas S, et al. Facilitation of HbS polymerization by the substitution of Glu for Gln at B121. J Biol Chem. 1988;263(12):607–610.
  • Torres LS, Okumura JV, Silva DG, et al. Hemoglobin D-Punjab: origin, distribution and laboratory diagnosis. Rev Bras Hematol Hemoter. 2015;37(2):120–126.
  • Nagel RL. The origin of the hemoglobin S gene: clinical, genetic and anthropological consequences. Einstein Quarterly J Biol Med. 1984;2:53–62.
  • Galiza Neto GC, Pitombeira MS, Vieira HF, et al. Análise dos haplótipos do gene da beta S-globina no Ceará. J Bras Patol Med Lab. 2005;41(5):315–321.
  • Figueiredo MS, Kerbauy J, Gonçalves MS, et al. Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil. Am J Hematol. 1996;53(2):72–76.
  • Lyra IM, Gonçalves MS, Braga JA, et al. Clinical, hematological, and molecular characterization of sickle cell anemia pediatric patients from two different cities in Brazil. Cad Saúde Pública. 2005;21(4):1287–1290.
  • Adorno EV, Zanette A, Lyra I, et al. Clinical and molecular characteristics of sickle cell anemia in northeast of Brazil. Genet Mol Biol. 2008;31(3):621–625.
  • Silva Filho IL, Ribeiro GS, Moura PG, et al. Sickle cell disease: acute clinical manifestations in early childhood and molecular characteristics in a group of children in Rio de Janeiro. Rev Bras Hematol Hemoter. 2012;34(3):196–201.
  • Luporini SM, Bendit I, Manhani R, et al. Growth hormone and insulin-like growth factor I axis and growth of children with different sickle cell anemia haplotypes. J Pediatr Hematol Oncol. 2001;23(6):357–363.
  • Charache S, Terrin ML, Moore RD, et al. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 1995 May 18;332(20):1317–1322.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.